BACTERIAL VAGINOSIS AND DESQUAMATIVE INFLAMMATORY VAGINITIS: CHOICE OF AN EFFECTIVE THERAPY METHOD. REVIEW
Relevance. Bacterial vaginosis and desquamative inflammatory vaginitis are one of the most common causes of patients' visits to gynecologists, primary care providers and emergency care centers. However, many women leave without a clear diagnosis or experience recurring symptoms despite treatment. The three most common etiologies of vaginitis are trichomonas, bacterial vaginosis and vulvovaginal candidiasis, which account for about 70% of cases. The remaining 30% may be related to other causes of vaginitis, including atrophic vaginitis, desquamative inflammatory vaginitis and erosive vaginal disease.
Aim of this review is to describe the common causes bacterial vaginosis and desquamative inflammatory vaginitis in order to increase the likelihood of accurate diagnosis, as well as effective and efficient therapy.
Search strategy. The study examined full-text publications in English and Russian, which are devoted epidemiology and treatment of bacterial vaginosis and desquamative inflammatory vaginitis. In the process of searching for literature, the following search engines were used: Pubmed, Web of science, Cyberleninka, Google Scholar by keywords. The time period was designated 2012-2022. 282 publications were identified on this topic. Of these, 52 publications corresponded to the purpose of our study. Inclusion criteria: Publications of the level of evidence A, B: meta-analyses, systematic reviews, cohort and cross-sectional studies. Exclusion criteria: summary reports, newspaper articles and personal messages.
Results and conclusions. As a result of numerous studies, it has been established that the vaginal pathway for the treatment of bacterial vaginosis and desquamative inflammatory vaginitis is not inferior in effectiveness to oral therapy. In addition, the vaginal route of treatment is more preferable due to the lower likelihood of adverse reactions.More research is needed to better characterize the cause and treatment of vaginosis and vaginitis. Some studies have shown an improvement in symptoms with the use of topical clindamycin or steroids; however, the ideal duration of treatment and the superiority of one remedy over the other have not been established.
Altynay A. Smagulova1,
Zaituna A. Khismetova1, https://orcid.org/0000-0001-5937-3045
Arailym K. Kamaliyeva1, Nazym S. Sagdatbek1
1 NCJSC “Semey medical university”, Semey с., Republic of Kazakhstan.
1. Anahtar M. N. [et al.]. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract // Immunity. 2015. № 5 (42). C. 965–976.
2. Bagnall P., Rizzolo D. Bacterial vaginosis: A practical review // JAAPA : official journal of the American Academy of Physician Assistants. 2017. № 12 (30). C. 15–21.
3. Bautista C. T. [et al.]. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections // Military Medical Research. 2016. № 1 (3).
4. Bautista C.T. [et al.]. Association of Bacterial Vaginosis With Chlamydia and Gonorrhea Among Women in the U.S. Army // American journal of preventive medicine. 2017. № 5 (52). C. 632–639.
5. Benyas D., Sobel J.D. Mixed Vaginitis Due to Bacterial Vaginosis and Candidiasis // Journal of lower genital tract disease. 2022. № 1 (26). C. 68–70.
6. Bilardi J.E. [et al.]. The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis // PloS one. 2013. № 9 (8).
7. Bradshaw C.S., Sobel J.D. Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation // The Journal of infectious diseases. 2016. № Suppl 1 (214 Suppl 1). C. S14–S20.
8. Coudray M.S., Madhivanan P. Bacterial vaginosis-A brief synopsis of the literature // European journal of obstetrics, gynecology, and reproductive biology. 2020. (245). C. 143–148.
9. Dionne-Odom J., Marrazzo J. Cervicitis: Balancing the Goals of Empiric Therapy and Antimicrobial Stewardship to Improve Women’s Health // Sexually transmitted diseases. 2020. № 6 (47). C. 387–388.
10. Donders G.G. [et al.]. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC) // Diagnostic microbiology and infectious disease. 2020. № 2 (97).
11. Donders G.G. [et al.]. Aerobic vaginitis: no longer a stranger // Research in microbiology. 2017. № 9–10 (168). C. 845–858.
12. Dovnik A. [et al.]. Treatment of vulvovaginal candidiasis: a review of the literature // Acta dermatovenerologica Alpina, Pannonica, et Adriatica. 2015. № 1 (24). C. 5–7.
13. Fan A. [et al.]. Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings // Archives of gynecology and obstetrics. 2013. № 2 (287). C. 329–335.
14. Fox E.P. [et al.]. Anaerobic bacteria grow within Candida albicans biofilms and induce biofilm formation in suspension cultures // Current biology : CB. 2014. № 20 (24). C. 2411–2416.
15. Gaydos C. A. [et al.]. Clinical Validation of a Test for the Diagnosis of Vaginitis // Obstetrics and gynecology. 2017. № 1 (130). C. 181–189.
16. Godha K. [et al.]. Human vaginal pH and microbiota: an update // Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2018. № 6 (34). C. 451–455.
17. Goje O. [et al.]. Diagnosis of Vaginitis: New Thinking for a New Era // Population health management. 2021. № 5 (24). C. 616–621.
18. Gosmann C. [et al.]. Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women // Immunity. 2017. № 1 (46). C. 29–37.
19. Hardy L. [et al.]. Unravelling the Bacterial Vaginosis-Associated Biofilm: A Multiplex Gardnerella vaginalis and Atopobium vaginae Fluorescence In Situ Hybridization Assay Using Peptide Nucleic Acid Probes // PloS one. 2015. № 8 (10).
20. Hillier S.L. [et al.]. Diagnosis and Treatment of Vaginal Discharge Syndromes in Community Practice Settings // Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021. № 9 (72). C. 1538–1543.
21. Jahic M. [et al.]. Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis // Medical archives (Sarajevo, Bosnia and Herzegovina). 2013. № 6 (67). C. 428–430.
22. Kenyon C., Colebunders R., Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review // American journal of obstetrics and gynecology. 2013. № 6 (209). C. 505–523.
23. Klatt N.R. [et al.]. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women // Science (New York, N.Y.). 2017. № 6341 (356). C. 938–945.
24. Kong A.M. [et al.]. Diagnostic Testing of Vaginitis: Improving the Value of Care // Population health management. 2021. № 4 (24). C. 515–524.
25. Li M. [et al.]. Prevalence and risk factors for bacterial vaginosis and cervicitis among 511 female workers attending gynecological examination in Changchun, China // Taiwanese journal of obstetrics & gynecology. 2019. № 3 (58). C. 385–389.
26. Liang Q. [et al.]. High-dose nifuratel for simple and mixed aerobic vaginitis: A single-center prospective open-label cohort study // The journal of obstetrics and gynaecology research. 2016. № 10 (42). C. 1354–1360.
27. Lohse M.B. [et al.]. Development and regulation of single- and multi-species Candida albicans biofilms // Nature reviews. Microbiology. 2018. № 1 (16). C. 19–31.
28. Mitchell C.M. [et al.]. Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women // American journal of obstetrics and gynecology. 2015. № 5 (212). C. 611.e1-611.e9.
29. Muzny C.A. [et al.]. Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective Study // The Journal of infectious diseases. 2018. № 6 (218). C. 966–978.
30. Muzny C.A. [et al.]. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis // Current opinion in infectious diseases. 2020. № 1 (33). C. 59–65.
31. Neal C.M. [et al.]. Noncandidal vaginitis: a comprehensive approach to diagnosis and management // American journal of obstetrics and gynecology. 2020. № 2 (222). C. 114–122.
32. Nwankwo T.O., Aniebue U.U., Umeh U.A. Syndromic Diagnosis in Evaluation of Women with Symptoms of Vaginitis // Current infectious disease reports. 2017. № 1 (19).
33. Nyirjesy P., Banker W.M., Bonus T.M. Physician Awareness and Adherence to Clinical Practice Guidelines in the Diagnosis of Vaginitis Patients: A Retrospective Chart Review // Population health management. 2020. № S1 (23). C. S13–S21.
34. Oerlemans E.F. M. [et al.]. The Dwindling Microbiota of Aerobic Vaginitis, an Inflammatory State Enriched in Pathobionts with Limited TLR Stimulation // Diagnostics (Basel, Switzerland). 2020. № 11 (10).
35. Paavonen J., Brunham R.C. Bacterial Vaginosis and Desquamative Inflammatory Vaginitis // The New England journal of medicine. 2018. № 23 (379). C. 2246–2254.
36. Qi W. [et al.]. Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis // Frontiers in cellular and infection microbiology. 2021. (11).
37. Reichman O., Sobel J. Desquamative inflammatory vaginitis // Best practice & research. Clinical obstetrics & gynaecology. 2014. № 7 (28). C. 1042–1050.
38. Reiter S., Kellogg Spadt S. Bacterial vaginosis: a primer for clinicians // Postgraduate medicine. 2019. № 1 (131). C. 8–18.
39. Saunders S. [et al.]. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms // Colloids and surfaces. B, Biointerfaces. 2007. № 2 (55). C. 138–142.
40. Scholes D. [et al.]. Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population // Sexually transmitted diseases. 2012. № 2 (39). C. 81–88.
41. Shen J. [et al.]. Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis // Scientific reports. 2016. (6).
42. Sherrard J. [et al.]. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge // International journal of STD & AIDS. 2018. № 13 (29). C. 1258–1272.
43. Smith S.B., Ravel J. The vaginal microbiota, host defence and reproductive physiology // The Journal of physiology. 2017. № 2 (595). C. 451–463.
44. Sonthalia S. [et al.]. Aerobic vaginitis - An underdiagnosed cause of vaginal discharge - Narrative review // International journal of STD & AIDS. 2020. № 11 (31). C. 1018–1027.
45. Soper D.E. Bacterial vaginosis and surgical site infections // American journal of obstetrics and gynecology. 2020. № 3 (222). C. 219–223.
46. Swidsinski A. [et al.]. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis // PloS one. 2013. № 1 (8).
47. Tidbury F.D. [et al.]. Non-antibiotic treatment of bacterial vaginosis-a systematic review // Archives of gynecology and obstetrics. 2021. № 1 (303). C. 37–45.
48. Tumietto F., Posteraro B., Sanguinetti M. Looking for appropriateness in the cure of mixed vaginitis: the role of fenticonazole as an empiric treatment // Future microbiology. 2019. (14). C. 1349–1355.
49. Venugopal S. [et al.]. Epidemiology and clinico-investigative study of organisms causing vaginal discharge // Indian journal of sexually transmitted diseases and AIDS. 2017. № 1 (38). C. 69–75.
50. Vieira-Baptista P. [et al.]. The International Society for the Study of Vulvovaginal Disease Vaginal Wet Mount Microscopy Guidelines: How to Perform, Applications, and Interpretation // Journal of lower genital tract disease. 2021. № 2 (25). C. 172–180.
51. Workowski K.A., Bolan G.A. Sexually transmitted diseases treatment guidelines, 2015 // MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2015. № RR-03 (64). C. 1–138.
52. Vaginitis: Diagnosis and Treatment - American Family Physician [Электронный ресурс]. URL: https://www.aafp.org/afp/2018/0301/p321.html (дата обращения: 24.02.2022).
Количество просмотров: 331
Категория статей:
Обзор литературы
Библиографическая ссылка
Smagulova A.A., Khismetova Z.A., Kamaliyeva A.K., Sagdatbek N.S. Bacterial vaginosis and desquamative inflammatory vaginitis: choice of an effective therapy method. Review // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 4, pp. 216-223. doi 10.34689/SH.2022.24.4.026Похожие публикации:
ДИАГНОСТИЧЕСКАЯ И ТЕРАПЕВТИЧЕСКАЯ ЛАПАРОСКОПИЯ ПРИ ТРАВМАХ ЖИВОТА. ОБЗОР ЛИТЕРАТУРЫ.
КАЧЕСТВО ЖИЗНИ И МЕТОДЫ ЕГО ОЦЕНКИ ПРИ ПЕРВИЧНОМ БИЛИАРНОМ ХОЛАНГИТЕ
ЛЕКАРСТВЕННО-ИНДУЦИРОВАННЫЕ ПОРАЖЕНИЯ ПЕЧЕНИ И ГЕНДЕРНЫЕ РАЗЛИЧИЯ
INTERRELATION OF INTRAABDOMINAL HYPERTENSION AND MARKERS OF GASTROINTESTINAL TRACT INJURY IN PATIENTS WITH MULTIORGAN DYSFUNCTION
НОВЫЕ СИНДРОМЫ И ПАТТЕРНЫ ОСТРОЙ ОККЛЮЗИИ КОРОНАРНЫХ АРТЕРИЙ. ОБЗОР ЛИТЕРАТУРЫ.